bpc-157 tb-500 investigational status BPC 157 (10mg) + TB 500 (10mg) Blend BPC-157 & TB-500 Peptide Therapy
Description
You can continue using the same vial through your dose increases, discarding only when the 28-day mark hits or when you have used the full 5mg
It manages immune response via an initial action on the cells of the innate immune system and this acts as an endogenous regulator of both inflammatory and adaptive immune responses
While it was originally studied for human use, its now being explored in veterinary medicine for its regenerative properties in dogs
FOR RESEARCH PURPOSES ONLY BPC-157 is not for human or animal consumption
